Spyglass Pharma, Inc. · NASDAQ:SGP
Srinivas Akkaraju reported a 6.30% stake in Spyglass Pharma, Inc. (Schedule 13G)
Event Feb 9, 2026 · Filed Feb 17, 2026
Srinivas Akkaraju reported a 6.30% stake in Spyglass Pharma, Inc., 2,109,953 shares, as a passive investor on Feb 9, 2026. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 2,109,953
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Samsara BioCapital, L.P. | 4.50% | 1,484,953 |
| Samsara BioCapital GP, LLC | 4.50% | 1,484,953 |
| Samsara Opportunity Fund, L.P. | 1.90% | 625,000 |
| Samsara Opportunity Fund GP, LLC | 1.90% | 625,000 |
| Srinivas Akkaraju | 6.30% | 2,109,953 |
Source
Related
- Spyglass Pharma, Inc.
- Srinivas Akkaraju
- Spyglass Pharma, Inc. shareholders
- Schedule 13D · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13D · New Enterprise Associates 17, L.P. · Feb 13, 2026
- Schedule 13D · Gilde Healthcare Holding B.V. · Feb 13, 2026
- Schedule 13G · Sands Frank M. · Feb 13, 2026
- Schedule 13D · Vensana Capital I GP, LLC · Feb 10, 2026